Fortress Biotech (FBIO)

FBIO NEWS

Roth Capital Analysts Increase Earnings Estimates for FBIO By MarketBeat - 1 month ago

Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) – Equities researchers at Roth Capital boosted their Q2 2025 earnings estimates for shares of Fortress Biotech in a research report issued on Tuesda… [+3929 chars]...

Read more
Wolverine Trading LLC Buys New Position in Fortress Biotech, Inc. (NASDAQ:FBIO) By MarketBeat - 1 month ago

Wolverine Trading LLC purchased a new position in shares of Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Secu… [+3624 chars]...

Read more
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics By Site Author - 1 month ago

MIAMI, May 30, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (Fortress), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value … [+6915 chars]...

Read more
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV By Journey - 1 month ago

National TV Segment Highlights FDA-Approved Treatment for Rosacea Segment premiered on Monday, June 9 and will be rebroadcast on Thursday, June 19, at 7:30 a.m. PT/ ET SCOTTSDALE, Ariz., June 09, 2… [+11116 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA
228.06 -1.95
-0.85%
CVX
150.01 -0.68
-0.45%
CAT
405.63 0.99
0.24%
INTC
22.43 -0.49
-2.16%
MSFT
503.88 -1.94
-0.38%
DIS
119.39 0.41
0.34%
DOW
27.74 -0.25
-0.89%
CSCO
67.24 0.06
0.08%
GS
697.09 -5.42
-0.77%